RA
GWPH

RFG Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

RFG Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,704
Closed -$347K – 470
2020
Q4 		$347K Buy
2,704
+305
+13% +$34.2K 0.05% 302
2020
Q3 		$234K Buy
2,399
+40
+2% +$4.6K 0.03% 361
2020
Q2 		$289K Buy
2,359
+30
+1% +$3.4K 0.04% 302
2020
Q1 		$204K Sell
2,329
-300
-11% -$31.8K 0.04% 321
2019
Q4 		$275K Buy
2,629
+171
+7% +$19.2K 0.05% 304
2019
Q3 		$283K Sell
2,458
-137
-5% -$20.8K 0.06% 257
2019
Q2 		$446K Buy
2,595
+239
+10% +$41.3K 0.1% 175
2019
Q1 		$396K Sell
2,356
-253
-10% -$37.6K 0.1% 167
2018
Q4 		$254K Buy
2,609
+38
+1% +$4.99K 0.06% 216
2018
Q3 		$444K Sell
2,571
-369
-13% -$53.2K 0.12% 174
2018
Q2 		$410K Buy
+2,940
New +$418K 0.12% 137

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RFG Advisory's GWPH Position: Q1 2021 in Review

RFG Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,704 shares — an estimated $347K sold.

RFG Advisory first reported a position in GWPH in Q2 2018 and held it in 11 quarters. The position peaked at $446K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • RFG Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • RFG Advisory sold 2,704 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $347K.
  • RFG Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 11 quarters.
  • RFG Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $446K in Q2 2019.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on RFG Advisory's 13F filing for Q1 2021, filed 19 Apr 2021.